| | 1305334-31-9 Basic information More.. |
| Product Name: | (16α)-21-Chloro-17-[(2-furanylcarbonyl)oxy]-16-Methyl-pregna-1,4-diene-3,11,20-trione | | Synonyms: | Mometasone Furoate EP Impurity C;(16α)-21-Chloro-17-[(2-furanylcarbonyl)oxy]-16-Methyl-pregna-1,4-diene-3,11,20-trione;Mometasone Furoate EP Impurity C/(8S,9S,10R,13S,14S,16R,17R)-17-(2-Chloroacetyl)-10,13,16-trimethyl-3,11-dioxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate;Mometasone Impurity C;(16±)-21-Chloro-17-[(2-furanylcarbonyl)oxy]-16-methyl-pregna-1,4-diene-3,11,20-trione\nMometasone Furoate Impurity C;Mometasone EP Impurity C;Mometasone Furoate Impurity 3(Mometasone Furoate EP Impurity C);Mometasone ImpurityEP-C | | CAS: | 1305334-31-9 | | MF: | C27H29ClO6 | | MW: | 484.97 | | EINECS: | | | Mol File: | 1305334-31-9.mol |  |
Use
As impurity of Mometasone Furoate, (16α)-21-Chloro-17-[(2-furanylcarbonyl)oxy]-16-Methyl-pregna-1,4-diene-3,11,20-trione can be used as a topical corticosteroid used as an anti-inflammatory.
|
|
1305334-31-9
Recommend Suppliers |
|